World's Best Scientists 2026 revealed!
Madhav V. Dhodapkar

Madhav V. Dhodapkar

D-Index & Metrics

Immunology

D-Index
89
Citations
34573
World Ranking
1104
National Ranking
589

Medicine

D-Index
89
Citations
34601
World Ranking
12549
National Ranking
6424

Overview

Madhav V. Dhodapkar is affiliated with Emory University in the United States. Their research primarily focuses on the field of Medicine, with significant contributions to subfields including Hematology, Oncology, Molecular Biology, Immunology, and Infectious Diseases.

The scientist's work extensively covers topics related to Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Protein Degradation and Inhibitors, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Cancer Treatment and Pharmacology, and SARS-CoV-2 and COVID-19 Research.

The publication record includes a range of peer-reviewed papers such as:

  • Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma, 2020, Journal of Clinical Oncology
  • Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial, 2020, The Lancet Haematology
  • Changes in Bone Marrow Tumor and Immune Cells Correlate with Durability of Remissions Following BCMA CAR T Therapy in Myeloma, 2022, Blood Cancer Discovery
  • Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression, 2021, Blood
  • Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma, 2024, Journal of Clinical Oncology

Their frequent co-authors include:

  • Sagar Lonial
  • Ajay K. Nooka
  • Jonathan L. Kaufman
  • Nisha S. Joseph
  • Craig C. Hofmeister

Madhav V. Dhodapkar has published extensively in several academic venues. The most common publication outlets are:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • Blood Cancer Discovery
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Antitumor activity of thalidomide in refractory multiple myeloma.

    S Singhal;J Mehta;R Desikan;D Ayers

  • Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.

    Madhav V. Dhodapkar;Ralph M. Steinman;Joseph Krasovsky;Christian Munz

  • Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris

    Edmund Jd Lee;William L. Trepicchio;Judith L Oestreicher;Debra D Pittman

  • Immune and Clinical Responses in Patients with Metastatic Melanoma to CD34+ Progenitor-derived Dendritic Cell Vaccine

    Jacques Banchereau;A. Karolina Palucka;Madhav Dhodapkar;Susan Burkeholder

  • Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study

    Alexander M. Lesokhin;Alexander M. Lesokhin;Stephen M. Ansell;Philippe Armand;Emma C. Scott

  • Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

    Benjamin Besse;Mélinda Charrier;Valérie Lapierre;Eric Dansin

  • A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma.

    Madhav V. Dhodapkar;Madhav V. Dhodapkar;Matthew D. Geller;David H. Chang;Kanako Shimizu

  • Dendritic cell function in vivo during the steady state: a role in peripheral tolerance.

    Ralph M. Steinman;Daniel Hawiger;Kang Liu;Laura Bonifaz

  • Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients

    David H. Chang;Keren Osman;John Connolly;Anjli Kukreja

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells

    M V Dhodapkar;R M Steinman;M Sapp;H Desai

  • Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells

    Kavita M. Dhodapkar;Joseph Krasovsky;Barbara Williamson;Madhav V. Dhodapkar;Madhav V. Dhodapkar

  • Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications.

    Radek Spisek;Anna Charalambous;Amitabha Mazumder;David H. Vesole

  • Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans.

    Madhav V. Dhodapkar;Ralph M. Steinman

  • Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo

    Rituparna Das;Rakesh Verma;Mario Sznol;Chandra Sekhar Boddupalli

  • International prognostic scoring system for Waldenstrom macroglobulinemia

    Pierre Morel;Alain Duhamel;Paolo Gobbi;Meletios A. Dimopoulos

  • Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients

    Devi K. Banerjee;Madhav V. Dhodapkar;Elyana Matayeva;Ralph M. Steinman

  • Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

    Fenghuang Zhan;Bart Barlogie;Varant Arzoumanian;Yongsheng Huang

  • Active immunization against cancer with dendritic cells: the near future.

    Ralph M. Steinman;Madhav Dhodapkar;Madhav Dhodapkar

  • Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

    Robert A. Kyle;Steven P. Treon;Raymond Alexanian;Bart Barlogie

Frequent Co-Authors

Sagar Lonial
Sagar Lonial Emory University
Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Lawrence H. Boise
Lawrence H. Boise Emory University
John Crowley
John Crowley Washington University in St. Louis
Vikas Gupta
Vikas Gupta Princess Margaret Cancer Centre
Richard A. Flavell
Richard A. Flavell Yale University
Robert Z. Orlowski
Robert Z. Orlowski The University of Texas MD Anderson Cancer Center
Frits van Rhee
Frits van Rhee University of Arkansas for Medical Sciences
Ralph M. Steinman
Ralph M. Steinman Rockefeller University
Till Strowig
Till Strowig Helmholtz Centre for Infection Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can expand career opportunities. Many students pivot toward nursing roles that complement their immunology knowledge, such as becoming a Licensed Practical Nurse (LPN) or a Nurse Practitioner (NP). Programs with easy admission LPN programs provide an accessible pathway to begin a healthcare career with less stringent entry requirements.

If you're considering advanced practice, several of the easiest NP programs to get into offer manageable admission criteria while still preparing graduates for rewarding roles in patient care and immunology-related specialties.

Mental health nursing often intersects with immunology through inflammatory and neurological conditions. Students interested in psychiatric nursing can benefit from PMHNP programs online with best clinical placement, which ensure hands-on experience through strong affiliations with healthcare facilities.

For those concerned about budget, exploring cheapest PMHNP certificate programs can make advanced psychiatric nursing education more accessible, helping students pursue specialized roles without overwhelming financial burden.

Best Scientists Citing Madhav V. Dhodapkar

Trending Scientists

Recently Published Articles